Why the study?
Are circulating cardiac-specific autoantibodies more frequent in patients with clinical myocarditis compared to ischaemic or normal controls?
Population
53 patients with clinical myocarditis from the Myocarditis Treatment Trial, mean age 42 +/- 15 years, 35…
Design
Case-control
Authors
Loading...
Supports autoimmune involvement in myocarditis; leaves open whether antibody testing should inform diagnosis or trials.
Are circulating cardiac-specific autoantibodies more frequent in patients with clinical myocarditis compared to ischaemic or normal controls?
Cardiac-specific autoantibodies are significantly more prevalent in patients with clinical myocarditis compared to controls, supporting an autoimmune component in a subset of patients regardless of biopsy findings.
Caforio et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: